Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 112   

Articles published

JNJ 100.82 -0.53 (-0.52%)
price chart
Johnson & Johnson's Media Search Excludes the U.S.
Johnson & Johnson's last big media review began in 2012 and concluded in 2013. It was not clear if the company would consider non-roster agencies in its search or how long it will take.
Johnson & Johnson global media review puts OMD on alert  Mumbrella Asia
Johnson & Johnson global media review puts OMD locally on alert over ...  MuMbrella
Johnson & Johnson Expects Lucrative Return on Drug Pipeline
Johnson & Johnson is predicting big returns from its prescription drug business, both financially and medically, as it develops treatments and strategies to intervene earlier and prevent or reduce the damage from several conditions, including Alzheimer ...
Johnson & Johnson Pegs Its Long-Term Growth Potential On Prevention  Forbes
Women are suing Johnson & Johnson over talcum powder
Johnson & Johnson's Shower to Shower is marketed as, "Just a sprinkle a day helps keep odor away." Yet now many women have filed lawsuits against Johnson & Johnson, arguing that talc in this and other products led to their ovarian cancers and that the ...
Women File Lawsuit Against Johnson & Johnson Over Talcum Powder  The Inquisitr
Johnson & Johnson's Piping-Hot Pipeline
We believe that Johnson & Johnson is positioned for solid growth, driven by strength of its pharmaceuticals business, recovery in the consumer segment and market stabilization coupled with share gain in medical devices and diagnostics.
Johnson & Johnson's Schizophrenia Drug Wins FDA Approval
Janssen Pharmaceuticals Inc., a unit of Johnson & Johnson, developed the atypical antipsychotic Invega Trinza, which was granted priority review in January.
Johnson & Johnson''s Schizophrenia Drug Gains FDA''s ...  Nasdaq
Johnson & Johnson (JNJ) Announces FDA Approval of Invega Trinza as ...  StreetInsider.com
Johnson & Johnson Now Offering Employees Up To 17 Weeks Of Parental Leave
This week, Johnson & Johnson made an exciting announcement that will hopefully set a precedent for other major companies in the U.S.
Johnson & Johnson To Give 8 Weeks Paid Leave For New Moms And Dads  RTT News
Johnson & Johnson and Achillion in $1.1 Billion Tie-Up
Under the exclusive global collaboration and licensing agreement, Johnson & Johnson's Janssen Pharmaceuticals Inc. subsidiary becomes responsible for all costs of developing and selling the treatment regimens.
Achillion and Johnson amp; Johnson in $1.1B HCV Tie-Up  Zacks.com
What Does The Johnson & Johnson/Achillion Deal Mean For HCV Competitors?  Benzinga
CNBC Exclusive: CNBC Transcript: Johnson & Johnson Chairman & CEO Alex ...
JOE KERNEN: JOHNSON & JOHNSON, WE'VE BEEN TALKING ABOUT THIS INTERVIEW, HOLDING A PHARMACEUTICAL ANALYST MEETING TODAY.
Johnson & Johnson Seeks to Deliver 10 Blockbusters
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ) might be stuck in a bit of a trading range over the past year, but that in no way reflects that its growth is at a standstill.
Interesting August Stock Options for Johnson & Johnson
So unless Johnson & Johnson sees its shares fall 5.8% and the contract is exercised (resulting in a cost basis of $96.26 per share before broker commissions, subtracting the $1.24 from $97.50), the only upside to the put seller is from collecting that ...